Elektrokonvulsionstherapie – Indikationsstellung und Durchführung bei pharmakotherapieresistenten psychiatrischen Erkrankungen

Lernziele

Der Artikel gibt den Lesern einen klinisch orientierten Überblick über den möglichen Einsatz der Elektrokonvulsionstherapie (EKT) bei schwierig zu behandelnden und pharmakotherapieresistenten depressiven Störungen. Es wird umfassend über Indikationsstellung, Wirksamkeit und Verträglichkeit inkl. der möglichen unerwünschten Wirkungen sowie über neue wissenschaftliche Entwicklungen informiert. Aufgrund der heute immer noch vorhandenen Stigmatisierung des Verfahrens wird zudem kurz über die Integration der EKT in die moderne Medizin und über die Anwendung des Therapieverfahrens in Therapiealgorithmen zur effektiven Behandlung depressiver Störungen informiert.

• Literatur

• 1 Diazgranados N, Ibrahim L, Brutsche NE et al. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 2010; 67 (08) 793-802
• 2 Zarate Jr CA, Singh JB, Carlson PJ et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006; 63 (08) 856-864
• 3 Mathew SJ, Shah A, Lapidus K et al. Ketamine for treatment-resistant unipolar depression: current evidence. CNS Drugs 2012; 26 (03) 189-204
• 4 World Health Organization. WHO resource book on mental health, human rights and legislation. 2005
• 5 Chanpattana W, Kramer BA, Kunigiri G et al. A survey of the practice of electroconvulsive therapy in Asia. J ECT 2010; 26 (01) 5-10
• 6 Leiknes KA, Jarosh-von SL, Hoie B. Contemporary use and practice of electroconvulsive therapy worldwide. Brain Behav 2012; 2 (03) 283-344
• 7 Scharfetter J, Frey R, Kasper S. Biologische Grundlagen der Elektrokonvulsionstherapie. In: Baghai TC, Frey R, Kasper S, et al. (Hrsg) Elektrokonvulsionstherapie – Klinische und wissenschaftliche Aspekte. Wien, New York: Springer; 2004: 87-105
• 8 Holtzmann J, Polosan M, Baro P et al. ECT: from neuronal plasticity to mechanisms underlying antidepressant medication effect. Encephale 2007; 33 (04) 572-578
• 9 Taylor SM. Electroconvulsive therapy, brain-derived neurotrophic factor, and possible neurorestorative benefit of the clinical application of electroconvulsive therapy. J ECT 2008; 24 (02) 160-165
• 10 Gedge L, Beaudoin A, Lazowski L et al. Effects of electroconvulsive therapy and repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor levels in patients with depression. Front Psychiatry 2012; 3: 12
• 11 Loh N, Nickl-Jockschat T, Sheldrick AJ et al. Accessibility, standards and challenges of electroconvulsive therapy in Western industrialized countries: A German example. World J Biol Psychiatry 2012;
• 12 Bustin J, Rapoport MJ, Krishna M et al. Are patients’ attitudes towards and knowledge of electroconvulsive therapy transcultural? A multi-national pilot study. Int J Geriatr Psychiatry 2008; 23 (05) 497-503
• 13 Rajagopal R, Chakrabarti S, Grover S et al. Knowledge, experience & attitudes concerning electroconvulsive therapy among patients & their relatives. Indian J Med Res 2012; 135: 201-210
• 14 Gangadhar BN, Kapur RL, Kalyanasundaram S. Comparison of electroconvulsive therapy with imipramine in endogenous depression: a double blind study. Br J Psychiatry 1982; 141: 367-371
• 15 Rothschild AJ. Management of psychotic, treatment-resistant depression. Psychiatr Clin North Am 1996; 19 (02) 237-252
• 16 Sauer H, Lauter H. Electroconvulsive therapy. II. Indications, contraindications and therapeutic technics of electroconvulsive therapy. Nervenarzt 1987; 58 (04) 210-218
• 17 Prudic J, Haskett RF, Mulsant B et al. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry 1996; 153 (08) 985-992
• 18 Sackeim HA. The definition and meaning of treatment-resistant depression. J Clin Psychiatry 2001; 62 (Suppl. 16) 10-17
• 19 Sartorius N, Baghai TC, Baldwin DS et al. Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence. Int J Neuropsychopharmacol 2007; 10 (Suppl. 01) S1-S207
• 20 Stassen HH, Angst J. Delayed Onset of Action of Antidepressants – Fact or Fiction?. CNS Drugs 1998; 9 (03) 177-184
• 21 Szegedi A, Jansen WT, van Willigenburg AP et al. Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients. J Clin Psychiatry 2009; 70 (03) 344-353
• 22 Folkerts HW, Michael N, Tolle R et al. Electroconvulsive therapy vs. paroxetine in treatment-resistant depression – a randomized study. Acta Psychiatr Scand 1997; 96 (05) 334-342
• 23 Flint AJ, Rifat SL. The treatment of psychotic depression in later life: a comparison of pharmacotherapy and ECT. Int J Geriatr Psychiatry 1998; 13 (01) 23-28
• 24 McCall WV. Electroconvulsive therapy in the era of modern psychopharmacology. Int J Neuropsychopharmacol 2001; 4 (03) 315-324
• 25 Rabheru K. Maintenance electroconvulsive therapy (M-ECT) after acute response: examining the evidence for who, what, when, and how?. J ECT 2012; 28 (01) 39-47
• 26 Frey R, Schreinzer D, Heiden A et al. Use of electroconvulsive therapy in psychiatry. Nervenarzt 2001; 72 (09) 661-676
• 27 Pfennig A, Bschor T, Baghai T et al. S3 guidelines on diagnostics and therapy of bipolar disorders: development process and essential recommendations. Nervenarzt 2012; 83 (05) 568-586
• 28 Grunze H, Schlosser S, Walden J. New perspectives in the acute treatment of bipolar depression. World J Biol Psychiatry 2000; 1 (03) 129-136
• 29 DeQuardo JR, Tandon R. Concurrent lithium therapy prevents ECT-induced switch to mania. J Clin Psychiatry 1988; 49 (04) 167-168
• 30 Aarre TF, Bugge P. ECT for patients taking lamotrigine. Eur Psychiatry 2002; 17 (Suppl. 01) 135
• 31 Zarate Jr CA, Tohen M, Baraibar G. Combined valproate or carbamazepine and electroconvulsive therapy. Ann Clin Psychiatry 1997; 9 (01) 19-25
• 32 Weiner RD, Coffey CE, Folk J et al. The Practice of Electroconvulsive Therapy. 2nd ed. Washington: American Psychiatric Association; 2001
• 33 Greenblatt M, Grosser GH, Wechsler HA. Differential response of hospitalized depressed patients in somatic therapy. Am J Psychiatry 1964; 120: 935-943
• 34 McDonald IM, Perkins M, Marjerrison G et al. A controlled comparison of amitriptyline and electroconvulsive therapy in the treatment of depression. Am J Psychiatry 1966; 122 (12) 1427-1431
• 35 Janicak PG, Davis JM, Gibbons RD et al. Efficacy of ECT: a meta-analysis. Am J Psychiatry 1985; 142 (03) 297-302
• 36 Rifkin A. ECT versus tricyclic antidepressants in depression: a review of the evidence. J Clin Psychiatry 1988; 49 (01) 3-7
• 37 Prudic J, Sackeim HA, Devanand DP. Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res 1990; 31 (03) 287-296
• 38 Dinan TG, Barry S. A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic nonresponders. Acta Psychiatr Scand 1989; 80 (01) 97-100
• 39 Sonawalla SB, Fava M. Severe depression: is there a best approach?. CNS Drugs 2001; 15 (10) 765-776
• 40 Kopecek M, Cerna L, Sulak J et al. Depressed patients perception of the efficacy of electroconvulsive therapy and venlafaxine therapy. Neuro Endocrinol Lett 2007; 28 (06) 889-894
• 41 Baghai TC, Marcuse A, Brosch M et al. The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World Journal of Biological Psychiatry In press
• 42 Sackeim HA, Prudic J, Devanand DP et al. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 2000; 57 (05) 425-434
• 43 Quitkin FM, McGrath PJ, Stewart JW et al. Can the effects of antidepressants be observed in the first two weeks of treatment?. Neuropsychopharmacology 1996; 15 (04) 390-394
• 44 Nobler MS, Sackeim HA, Moeller JR et al. Quantifying the speed of symptomatic improvement with electroconvulsive therapy: comparison of alternative statistical methods. Convuls Ther 1997; 13 (04) 208-221
• 45 Nothdurfter C, Eser D, Schule C et al. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World J Biol Psychiatry 2006; 7 (03) 162-170
• 46 Lehman AF, Lieberman JA, Dixon LB et al. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry 2004; 161 (Suppl. 02) 1-56
• 47 American Psychiatric Association. The Practice of ECT: Recommendations for Treatment, Training and Privileging. Convuls Ther 1990; 6 (02) 85-120
• 48 Lehnhardt FG, Konkol C, Kuhn J. Use of ECT in Drug-Refractory Schizophrenia – A Survey of the Current Literature. Fortschr Neurol Psychiatr 2012; 80: 501-511
• 49 Beale MD, Kellner CH, Pritchett JT et al. ECT for OCD. J Clin Psychiatry 1995; 56 (02) 81-82
• 50 Rabheru K, Persad E. A review of continuation and maintenance electroconvulsive therapy. Can J Psychiatry 1997; 42 (05) 476-484
• 51 Sareen J, Enns MW, Guertin JE. The impact of clinically diagnosed personality disorders on acute and one-year outcomes of electroconvulsive therapy. J ECT 2000; 16 (01) 43-51
• 52 Zorumski CF, Rutherford JL, Burke WJ et al. ECT in primary and secondary depression. J Clin Psychiatry 1986; 47 (06) 298-300
• 53 Murray GB, Shea V, Conn DK. Electroconvulsive therapy for poststroke depression. J Clin Psychiatry 1986; 47 (05) 258-260
• 54 Hackett ML, Anderson CS, House A et al. Interventions for treating depression after stroke. Cochrane Database Syst Rev 2008; 4: CD003437
• 55 Oudman E. Is electroconvulsive therapy (ECT) effective and safe for treatment of depression in dementia? A short review. J ECT 2012; 28 (01) 34-38
• 56 Abrams R. Electroconvulsive Therapy. 4th ed. Oxford, New York: Oxford University Press; 2002
• 57 Baghai TC, Eser D, Schüle C et al. Elektrokonvulsionstherapie bei depressiven Störungen. Journal für Neurologie, Neurochirurgie und Psychiatrie 2005; 4: 20-28
• 58 Abrams R. The mortality rate with ECT. Convuls Ther 1997; 13 (03) 125-127
• 59 Shiwach RS, Reid WH, Carmody TJ. An analysis of reported deaths following electroconvulsive therapy in Texas, 1993–1998. Psychiatr Serv 2001; 52 (08) 1095-1097
• 60 Dersch R, Zwernemann S, Voderholzer U. Partial status epilepticus after electroconvulsive therapy and medical treatment with bupropion. Pharmacopsychiatry 2011; 44 (07) 344-346
• 61 Kamel H, Cornes SB, Hegde M et al. Electroconvulsive therapy for refractory status epilepticus: a case series. Neurocrit Care 2010; 12 (02) 204-210
• 62 Pogarell O, Ehrentraut S, Ruther T et al. Prolonged confusional state following electroconvulsive therapy – diagnostic clues from serial electroencephalography. Pharmacopsychiatry 2005; 38 (06) 316-320
• 63 Fink M. Interseizure EEG Slowing after ECT is not NCSE. Pharmacopsychiatry 2006; 39 (03) 119
• 64 Reimherr FW, Hodges MR, Hill GE et al. Prolongation of muscle relaxant effects by lithium carbonate. Am J Psychiatry 1977; 134 (02) 205-206
• 65 Markowitz JS, Kellner CH, DeVane CL et al. Intranasal sumatriptan in post-ECT headache: results of an open-label trial. J ECT 2001; 17 (04) 280-283
• 66 Calev A, Gaudino EA, Squires NK et al. ECT and non-memory cognition: a review. Br J Clin Psychol 1995; 34 (04) 505-515
• 67 Lisanby SH, Maddox JH, Prudic J et al. The effects of electroconvulsive therapy on memory of autobiographical and public events. Arch Gen Psychiatry 2000; 57 (06) 581-590
• 68 Semkovska M, McLoughlin DM. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol Psychiatry 2010; 68 (06) 568-577
• 69 Devanand DP, Fitzsimons L, Prudic J et al. Subjective side effects during electroconvulsive therapy. Convuls Ther 1995; 11 (04) 232-240
• 70 Calev A, Nigal D, Shapira B et al. Early and long-term effects of electroconvulsive therapy and depression on memory and other cognitive functions. J Nerv Ment Dis 1991; 179 (09) 526-533
• 71 Krystal AD, Coffey CE. Neuropsychiatric considerations in the use of electroconvulsive therapy. J Neuropsychiatry Clin Neurosci 1997; 9 (02) 283-292
• 72 Delva NJ, Brunet D, Hawken ER et al. Electrical dose and seizure threshold: relations to clinical outcome and cognitive effects in bifrontal, bitemporal, and right unilateral ECT. J ECT 2000; 16 (04) 361-369
• 73 Ng C, Schweitzer I, Alexopoulos P et al. Efficacy and cognitive effects of right unilateral electroconvulsive therapy. J ECT 2000; 16 (04) 370-379
• 74 Cohen D, Taieb O, Flament M et al. Absence of cognitive impairment at long-term follow-up in adolescents treated with ECT for severe mood disorder. Am J Psychiatry 2000; 157 (03) 460-462
• 75 Pettinati HM, Bonner KM. Cognitive functioning in depressed geriatric patients with a history of ECT. Am J Psychiatry 1984; 141 (01) 49-52
• 76 Agelink MW, Andrich J, Postert T et al. Relation between electroconvulsive therapy, cognitive side effects, neuron specific enolase, and protein S-100. J Neurol Neurosurg Psychiatry 2001; 71 (03) 394-396
• 77 ECT review group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 2003; 361 (9360) 799-808
• 78 Sackeim HA, Prudic J, Devanand DP et al. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med 1993; 328 (12) 839-846
• 79 Ostroff R, Gonzales M, Sanacora G. Antidepressant effect of ketamine during ECT. Am J Psychiatry 2005; 162 (07) 1385-1386
• 80 Okamoto N, Nakai T, Sakamoto K et al. Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: comparing ketamine and propofol anesthesia. J ECT 2010; 26 (03) 223-227
• 81 Viswanath B, Narayanaswamy JC, Thirthalli J et al. Effectiveness of Bifrontal ECT in Practice: A Comparison with Bitemporal ECT. Indian J Psychol Med 2011; 33 (01) 66-70
• 82 Eschweiler GW, Vonthein R, Bode R et al. Clinical efficacy and cognitive side effects of bifrontal versus right unilateral electroconvulsive therapy (ECT): a short-term randomised controlled trial in pharmaco-resistant major depression. J Affect Disord 2007; 101 (01) 149-157
• 83 Sienaert P. Bifrontal, bitemporal and right unilateral ECT electrode placement are similarly effective for reducing depressive symptoms. Evid Based Ment Health 2010; 13 (03) 85
• 84 Quante A, Luborzewski A, Brakemeier EL et al. Effects of 3 different stimulus intensities of ultrabrief stimuli in right unilateral electroconvulsive therapy in major depression: a randomized, double-blind pilot study. J Psychiatr Res 2011; 45 (02) 174-178